Bulls holding strong on VITROMXSTO:VITR
Despite several attemps from the bears to reach the 160 level, the bulls are stronly in control.
It got cheap in the process. Probably a good opportunity.
Risk 15%
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.34 EUR
44.60 M EUR
313.76 M EUR
72.50 M
About VITROLIFE AB
Sector
Industry
CEO
Bronwyn Brophy O'Connor
Website
Headquarters
Gothenburg
Founded
1989
ISIN
SE0011205202
FIGI
BBG000DPCYC8
Vitrolife AB develops, produces, and markets products for creating, prolonging, and improving life. It focuses on fertility treatments, cell therapy and tissue engineering, and organ transplantation systems. The company was founded in 1994 and is headquartered in Gothenburg, Sweden.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange VITROLIFE AB SK 0,2 stocks are traded under the ticker VTFN.
We've gathered analysts' opinions on VITROLIFE AB SK 0,2 future price: according to them, VTFN price has a max estimate of 23.89 EUR and a min estimate of 20.22 EUR. Watch VTFN chart and read a more detailed VITROLIFE AB SK 0,2 stock forecast: see what analysts think of VITROLIFE AB SK 0,2 and suggest that you do with its stocks.
VTFN reached its all-time high on Nov 1, 2021 with the price of 57.25 EUR, and its all-time low was 10.41 EUR and was reached on Mar 24, 2020. View more price dynamics on VTFN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track VITROLIFE AB SK 0,2 financials in yearly and quarterly reports right on TradingView.
VITROLIFE AB SK 0,2 is going to release the next earnings report on Jul 17, 2025. Keep track of upcoming events with our Earnings Calendar.
VTFN earnings for the last quarter are 0.07 EUR per share, whereas the estimation was 0.08 EUR resulting in a −19.57% surprise. The estimated earnings for the next quarter are 0.11 EUR per share. See more details about VITROLIFE AB SK 0,2 earnings.
VITROLIFE AB SK 0,2 revenue for the last quarter amounts to 77.21 M EUR, despite the estimated figure of 80.77 M EUR. In the next quarter, revenue is expected to reach 83.50 M EUR.
VTFN net income for the last quarter is 9.26 M EUR, while the quarter before that showed 12.08 M EUR of net income which accounts for −23.36% change. Track more VITROLIFE AB SK 0,2 financial stats to get the full picture.
Yes, VTFN dividends are paid annually. The last dividend per share was 0.10 EUR. As of today, Dividend Yield (TTM)% is 0.71%. Tracking VITROLIFE AB SK 0,2 dividends might help you take more informed decisions.
As of May 31, 2025, the company has 1.12 K employees. See our rating of the largest employees — is VITROLIFE AB SK 0,2 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VITROLIFE AB SK 0,2 EBITDA is 114.71 M EUR, and current EBITDA margin is 34.30%. See more stats in VITROLIFE AB SK 0,2 financial statements.
Like other stocks, VTFN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VITROLIFE AB SK 0,2 stock right from TradingView charts — choose your broker and connect to your account.